| Ytd | 15.75% | |
| 1y | -77.74% |
| Open | 5.02 | Prev Close | 2.97 | Low | 3.82 | High | 5.98 | Mkt Cap | 9.92M |
| Vol | 57.03M | Avg Vol | 1.84M | EPS | -10.75 | P/E | N/A | Forward P/E | -2.00 |
| Beta | 0.57 | Short Ratio | 1.96 | Inst. Own | 8.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 3.18 | 200-d Avg | 5.52 | 1yr Est | 14.00 |
CANF News
Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se
Can-Fite BioPharma Ltd. (NYSE:CANF) on Wednesday said its Phase 2a study of Namodenoson in advanced
Can-Fite's Phase 2a Namodenoson study met its safety endpoint and showed durable survival, suppo
Three emerging biotechnology companies, Can-Fite (NYSE: CANF), NeOnc (NASDAQ: NTHI), and PMGC (NASDA
Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's
NKE: -9% | Nike shares are trading lower. The company reported Q4 financial results. BE: 12% | Bloom
Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced d
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday&
Can-Fite stock rises after Japan patent allowance strengthens Namodenoson’s obesity and metabolic di
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m
ON: -14% | ON stock has given up its prior gain. ON Semiconductor shares were trading higher after t
The allowed Patent strengthens protection in one of the world's largest pharmaceutical markets a
Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of pr
Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a clinical-stage biotechnology company developing